nalidixic acid

Preferred Label : nalidixic acid;

MeSH definition : A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.;

MeSH synonym : acid, nalidixic; nalidixin;

MeSH hyponym : nalidixate sodium anhydrous; nalidixate sodium; nevigramon; Anhydrous, Nalidixate Sodium; Sodium Anhydrous, Nalidixate; Sodium Nalidixic Acid, Anhydrous; Sodium, Nalidixate; Sodium Nalidixic Acid, Monohydrate;

MeSH CAS label : 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-;

MeSH Related Number : 15769-77-4 (Na salt, monohydrate); 389-08-2 (Nalidixic acid); nalidixate sodium anhydrous; nalidixate sodium; J17QL41ZAG; Y7NU182221;

Registry Number MeSH : 389-08-2;

Related CAS MeSH : Y7NU182221 (Nalidixate sodium anhydrous); J17QL41ZAG (Nalidixate sodium);

Wikipedia link : https://en.wikipedia.org/wiki/Nalidixic acid;

Codes EINECS : 206-864-7;

Is substance : O;

UNII : 3B91HWA56M;

InChIKey : MHWLWQUZZRMNGJ-UHFFFAOYSA-N;

Details

Origin ID

D009268;

UMLS CUI

C0027353;

ATC code(s)
- nalidixic acid [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- nalidixic acid [Substance BNPC]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- enzyme inhibitors [MeSH Descriptor]
- topoisomerase II inhibitors [MeSH Descriptor]
Record concept(s)
- nalidixate sodium [MeSH concept]
- nalidixate sodium anhydrous [MeSH concept]
- nalidixic acid [MeSH concept]
- nevigramon [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-methyl-7-(2-(5-nitro-2-furyl)vinyl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate [MeSH Supplementary Concept]
- 7-carboxynalidixic acid [MeSH Supplementary Concept]
- 7-hydroxynalidixic acid [MeSH Supplementary Concept]
- PA 2789 [MeSH Supplementary Concept]
- PA 2808 [MeSH Supplementary Concept]
- amfonelic acid [MeSH Supplementary Concept]
- citrated nalidixic acid [MeSH Supplementary Concept]
- erythromycin nalidixate [MeSH Supplementary Concept]
- nalidixic acid amphotericin B vancomycin medium [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Nalidixic Acid [NCIt concept]
- Nalidixic acid [ICD-11 Extension code]
- Nalidixic acid (substance) [SNOMED CT concept]
- Product containing nalidixic acid (medicinal product) [SNOMED CT concept]
- nalidixic acid [ATC Code]
- nalidixic acid [Substance BNPC]
- nalidixic acid [SNOMED Notion]
Validated automatic mappings to BTNT
- nalidixic acid [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients